Uveitis Treatment

Global Market Trajectory & Analytics

MCP15425

EXECUTIVE ENGAGEMENTS

OUTREACH

876
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

173
Interactions with Platform & by Email

PARTICIPANTS

33
Unique # Participated

VALIDATIONS

16
Responses Validated*

COMPETITORS

42
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

32

PAGES

104

EDITION

8

PRICE

USD $4950


  

HIGHLIGHTS

Amid the COVID-19 crisis, the global market for Uveitis Treatment estimated at US$640.1 Million in the year 2020, is projected to reach a revised size of US$875.5 Million by 2027, growing at a CAGR of 4.6% over the period 2020-2027.
The Uveitis Treatment market in the U.S. is estimated at US$188.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$154.9 Million by the year 2027 trailing a CAGR of 4.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.4% and 3.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

SELECT PLAYERS

AbbVie, Inc.; Alcon, a Novartis Company; Allergan PLC; Bausch & Lomb, Inc.; Enzo Biochem, Inc.; Hanbell Precise Machinery Co. Ltd.; Psivida Corporation; Regeneron Pharmaceuticals, Inc.; Santen Pharmaceutical Co., Ltd.; TopiVert Ltd.; XOMA Corporation

SEGMENTS

» Segment (Uveitis)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Uveitis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Uveitis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Uveitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Uveitis Treatment by Segment - Uveitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Uveitis Treatment by Segment - Uveitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
CANADA
Canada Current & Future Analysis for Uveitis Treatment by Segment - Uveitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Uveitis Treatment by Segment - Uveitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
JAPAN
Japan Current & Future Analysis for Uveitis Treatment by Segment - Uveitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Uveitis Treatment by Segment - Uveitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
CHINA
China Current & Future Analysis for Uveitis Treatment by Segment - Uveitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Uveitis Treatment by Segment - Uveitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
EUROPE
Europe Current & Future Analysis for Uveitis Treatment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Uveitis Treatment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Uveitis Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Uveitis Treatment by Segment - Uveitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Uveitis Treatment by Segment - Uveitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
GERMANY
Germany Current & Future Analysis for Uveitis Treatment by Segment - Uveitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Uveitis Treatment by Segment - Uveitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
ITALY
Italy Current & Future Analysis for Uveitis Treatment by Segment - Uveitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Uveitis Treatment by Segment - Uveitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UNITED KINGDOM
UK Current & Future Analysis for Uveitis Treatment by Segment - Uveitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Uveitis Treatment by Segment - Uveitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
REST OF EUROPE
Rest of Europe Current & Future Analysis for Uveitis Treatment by Segment - Uveitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Uveitis Treatment by Segment - Uveitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Uveitis Treatment by Segment - Uveitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Uveitis Treatment by Segment - Uveitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
REST OF WORLD
Rest of World Current & Future Analysis for Uveitis Treatment by Segment - Uveitis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Uveitis Treatment by Segment - Uveitis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Total Companies Profiled: 42

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com